Iluvien provides a continuous low-dose of steroids to treat diabetic macular edema. The treatment received FDA approval in 2014.
More articles on ASC issues:
10 best states for retirement
How to turn ASC staffing from a cost-center into a value center – 8 key steps
Healthcare services M&A: 10 key trends
